Traveling with HIV — the world is still ours to see.

Travel is a right, not a risk

People living with HIV get on planes every day — to close business deals, to visit family, to snorkel a reef, to stand in a crowd of two million people during Hajj. That is the ordinary shape of life on modern antiretroviral therapy (ART). The CDC's Yellow Book, the reference U.S. clinicians use for pre-travel counseling, says it plainly: people with well-controlled HIV who are on ART and regularly engaged in care should feel comfortable traveling, because many thousands already do, every year.1

That confidence rests on three pillars: modern treatment that keeps viral load undetectable through time-zone changes and missed-by-a-few-hours doses; long-acting injectable options that shrink "what do I pack" down to a single monthly, bimonthly, or twice-yearly appointment; and documentation habits — a doctor's letter, copies of prescriptions, a little advance planning — that make border crossings unremarkable. None of this requires disclosing HIV status to anyone with no legal right to ask.

This guide is built around two questions travelers actually ask: What do I need to do differently because I live with HIV? and Where does the world still treat HIV status as a border issue instead of a health issue? The honest answer to the second: a shrinking, nameable list of countries — naming them, rather than gesturing at "some places," is what lets you plan instead of worry.

Entry restrictions in 2026 — the real list, and the real trend

Roughly 50 countries and territories still require HIV testing or otherwise restrict entry, stay, or residence based on HIV status, according to CDC's 2026 Yellow Book chapter on travelers with HIV, developed using Positive Destinations and the UNAIDS HIV-related travel restrictions database.1 That number keeps shrinking: in 2004, UNAIDS and the International Organization for Migration jointly declared HIV-related travel restrictions have no public health justification at all.1

Two dates anchor the modern history. The U.S. banned entry for people with HIV from 1987 until Congress removed the statutory language in 2008, with the remaining regulatory restrictions rescinded in 2010.1 China removed its HIV-specific entry restrictions the same year, and Namibia abolished its HIV-related immigration barriers on July 1, 2010.6 New Zealand followed in October 2021, removing HIV from its list of "high-cost" medical conditions that could trigger a residency denial — UNAIDS Executive Director Winnie Byanyima called it a step she hoped would "encourage other countries to remove all travel restrictions and other policies that discriminate against people living with HIV."2

Who still restricts entry, and how

CDC's 2026 Yellow Book lists the following countries as ones that may deport a traveler discovered to have HIV: Bahrain, Brunei, Cook Islands, Egypt, Iraq, Jordan, Kuwait, Lebanon, Malaysia, North Korea, Oman, Qatar, Russia, Saudi Arabia, Singapore, Solomon Islands, Sudan, Syria, Turkmenistan, the United Arab Emirates, and Yemen — a list that can change, so the UNAIDS and Positive Destinations databases are the sources to check closest to any trip.1

The practical texture matters more than the raw list. Most restrictions apply to long-term stays — over 90 days, or any stay requiring a residency or work permit — rather than short tourist or business visits.1 aidsmap's travel guidance confirms the same pattern: tourism or business trips are generally possible even in countries with entry bans, because the ban is triggered by a residence or work-permit medical exam, not a passport stamp.3 The U.S. State Department's advisory for Saudi Arabia states this distinction directly: no restrictions for visitors on temporary tourist visas, but a work or residency permit requires a medical exam that screens for HIV, and testing positive disqualifies the work authorization.4

The United Arab Emirates is the starkest exception to the "tourism is fine" pattern. The Global Network of People Living with HIV (GNP+) has stated that people living with HIV are not permitted to enter or stay in the UAE at all, that anyone found living with HIV is deported immediately, and that the country does not allow personal import of antiretrovirals or provide HIV care to those who are there — conditions GNP+ called clear violations of human rights.5 If UAE transit is unavoidable, the practical move is a short connection that avoids any layover requiring a visa or medical exam.

Practical implications for tourism, work visas, and long stays

A two-week vacation is almost never a problem — no country on the list screens tourists for HIV at the border. A student visa, work permit, or residency application changes the calculation: New Zealand, for example, still requires HIV testing for any visa applicant staying more than 12 months, even though HIV status no longer automatically disqualifies the application.2 The safest approach for any stay longer than 90 days is to contact the destination's embassy or consulate before applying, framing the question generically about "chronic condition" medical screening rather than disclosing HIV status directly.1

Packing your meds — what actually crosses borders smoothly

The 2026 Yellow Book restates the packing basics with useful precision: carry HIV medications and all others in their original packaging, with labels identifying medication, dosing, and patient information.1 Bring a few extra days' supply beyond what the trip requires, and keep medications in carry-on luggage — checked bags are the ones that get lost or delayed.1

A signed clinician's letter is the single most useful document you can carry. CDC notes a healthcare professional can document that a regimen is prescribed for a medical condition without naming HIV specifically — the letter just needs to establish the medications are legitimately prescribed.1 aidsmap's traveler guidance adds that keeping your usual pill-taking routine — same meal, same rough time of day — supports adherence better than any specific packing trick.3

TSA and U.S. security screening

TSA does not require disclosure of what a medication treats. Medications in original, labeled containers pass through security screening without issue.7 Medically necessary liquid medications are exempted from the standard 3.4-ounce carry-on limit — simply declare them before screening. Injectable ART, syringes, and needles are permitted in carry-on baggage when accompanied by the medication they administer.

What NOT to do

Do not repackage pills into unlabeled containers to hide what they are — an unlabeled bottle is more likely to trigger a customs question than a labeled one with a generic-sounding brand name like Biktarvy or Dovato. If medication is confiscated at a border — rare, but documented in a handful of countries with strict import controls — the fastest recovery path is your home HIV clinic, the nearest U.S. embassy or consulate, or the International Association for Medical Assistance to Travellers, a global directory of vetted providers.8

Long-term stays need a different prescription strategy

For extended travel, ask your clinician about switching a 30-day prescription to a 90-day supply, and identify where you'd access HIV care at the destination if you needed a refill.1 Some countries restrict the quantity of medication that can be imported at once, so check with the destination's embassy if the stay runs past three months.1 Ryan White HIV/AIDS Program clinics and most ADAP formularies allow a "vacation override" for early refills; ask two to three weeks before departure.

Long-acting injectables and travel logistics

Long-acting injectable ART changes the travel conversation more than almost any development in the last decade, because it removes daily pills from the equation for weeks or months at a stretch. The two options for people already living with HIV are injectable cabotegravir/rilpivirine (Cabenuva) — monthly or every-two-months — and lenacapavir (Sunlenca), used with an optimized background regimen for multidrug-resistant HIV, dosed twice yearly after an oral lead-in.9 A third injectable, Yeztugo (lenacapavir), was FDA-approved in June 2025 as pre-exposure prophylaxis (PrEP) for HIV-negative people — relevant if your travel partner is the HIV-negative half of a mixed-status couple and uses twice-yearly injectable PrEP rather than daily pills.10

The real logistics problem: schedule sync, not refrigeration

The genuine planning challenge is timing the next dose around travel, since these are clinician-administered — you cannot self-inject and adjust the way you can swallow a pill an hour early. Cabenuva's monthly or bimonthly window and Sunlenca's twice-yearly cadence (with a ±2-week flexibility window) mean a trip needs to be checked against the calendar before it's booked.9 If a scheduled injection falls during a trip, three options work: shift the appointment within the label's flexibility window, find a destination clinic that stocks the same product, or ask your clinician about a temporary oral bridge — some long-acting regimens have an approved interim oral strategy for exactly this.13

Because rescheduling and cross-border clinic coordination take real time, plan the conversation with your HIV clinician 4 to 6 weeks before departure — enough runway to shift an appointment or discuss a bridging strategy without last-minute scrambling.13

Time zones and dosing — across the clock without missing a beat

Most modern single-tablet ART regimens tolerate real flexibility in dose timing. Integrase-based regimens especially have wide forgiveness windows, and stable, virally suppressed patients who take one dose a few hours early or late because of a time-zone shift generally do not experience clinical problems.3 aidsmap and most HIV clinicians recommend adapting to local time as quickly as possible after arrival and keeping your usual routine — same meal, just at the new local time.3

For trips crossing more than six time zones, three approaches all work:

• Gradual shift: move your dose time by two to three hours per day for two to three days before departure, arriving already close to destination time.
• Stay on origin time: keep dosing on your home clock for the whole trip (a phone alarm makes this simple), then shift back once home.
• Direct switch for large offsets: for roughly a 12-hour difference, such as U.S. to Vietnam, switching straight to the "opposite" clock time works cleanly if you've been consistent.

The one universal rule: never skip a dose entirely to "reset" a schedule. A gap stretched to 26 or even 30 hours is a minor, usually inconsequential deviation for someone with a suppressed viral load on modern ART; an entirely skipped dose is what risks viral rebound and, with repetition, resistance.14 If unsure how forgiving your regimen is, ask your clinician rather than guessing. For adherence tools beyond travel, see our companion guide on treatment and adherence.

Vaccines — what's safe, what's held for CD4 count, what's new

CDC's 2026 Yellow Book, authored by Robert A. Bonacci and Eric S. Halsey, lays out vaccine guidance for travelers with HIV in detail. The underlying principle: inactivated vaccines are generally safe regardless of CD4 count, while live vaccines require a CD4 threshold because they carry a small risk of causing the disease they prevent in someone with insufficient immune reconstitution.1

Recommended for essentially everyone with HIV

Hepatitis A and hepatitis B vaccination are recommended for all people with HIV, with post-vaccination antibody testing to confirm an adequate immune response.1 Inactivated or recombinant influenza vaccine, pneumococcal vaccination, tetanus/diphtheria/pertussis boosters, and recombinant zoster vaccine (RZV) — recommended for all people with HIV aged 18 and older, younger than the general-population recommendation — round out the routine list.1

Live vaccines and the CD4 threshold

Yellow fever vaccination is the clearest example of CD4-dependent guidance: a precaution for CD4 counts of 200–499 cells/mm³, essentially fine to give at CD4 ≥500, and contraindicated below 200 or with symptomatic HIV.1 If contraindicated and the itinerary can't change, CDC calls for a medical waiver plus rigorous mosquito-avoidance measures.1 MMR follows a similar pattern: recommended for people with HIV over age 1 without evidence of immunity, unless they meet the definition of severe immunosuppression (broadly, CD4 under 200 for more than six months in adults).1 Live oral typhoid vaccine (Ty21a) and smallpox vaccine ACAM2000 are contraindicated outright for people with HIV regardless of CD4 count.1

New for 2024–2026: mpox and RSV

The mpox vaccine JYNNEOS is recommended for people with HIV who have had recent or anticipated mpox exposure; it's replication-incompetent, so it's considered safe even though effectiveness may run lower with more severe immunosuppression.1 RSV vaccination is now recommended for everyone 75 and older regardless of HIV status, and for adults 60–74 at increased risk — a category that explicitly includes moderate or severe immunocompromise.1

Malaria prophylaxis and ART interactions

Malaria risk and disease severity are both increased in people with HIV, especially with advanced disease — CDC recommends people with a low CD4 count consider delaying travel to malaria-endemic areas, and pregnant people living with HIV should consider delaying such travel regardless of CD4 count, given how limited safe prophylaxis options become in pregnancy.1 When travel can't be deferred, effective chemoprophylaxis plus rigorous mosquito-bite precautions — treated bed nets, DEET repellents, covering clothing — are both essential and, together, highly effective.1

The antimalarial-to-ART interaction table matters because the four commonly prescribed prophylaxis options interact differently with different antiretroviral backbones, and the University of Liverpool's HIV Drug Interactions checker is the primary tool CDC itself cites for working through them.15

The bottom line: bring your full ART regimen and formulation to a travel medicine consultation, run it through the Liverpool checker with your prescriber, and don't assume your travel companion's antimalarial is automatically fine for you — the interaction differs by exact regimen.15

TB screening before and after high-burden travel

Tuberculosis screening is not something every traveler with HIV needs before every trip — CDC limits routine tuberculin skin test (TST) or interferon-gamma release assay (IGRA) screening to people with defined higher-risk exposures: healthcare workers, people with prolonged residence of more than six months in a high-TB-burden area, and similar extended contact with residents of highly TB-endemic regions.16 A two-week beach vacation does not, by itself, trigger a screening recommendation.

When screening is indicated, IGRA has a practical advantage: fewer visits than TST, and less likely to produce a false positive in someone who received BCG vaccination as a child — common for people who grew up outside the U.S.16 Any positive result should be followed by a full evaluation for active TB symptoms and a chest X-ray before latent infection is assumed and treated.16 For people living with HIV, untreated latent TB progresses to active disease more readily with HIV-related immune suppression — one more reason not to skip post-travel screening if your exposure qualifies, even feeling completely well.

STIs abroad — doxy-PEP, condoms, and PrEP for a negative partner

Sexual health abroad deserves the same plain, non-judgmental treatment as any other travel health topic. Doxycycline post-exposure prophylaxis (doxy-PEP) — a single 200 mg dose taken within 72 hours after sex — is now a CDC-recommended strategy for gay and bisexual men and transgender women who've had a bacterial STI diagnosed in the past year, reducing syphilis and chlamydia by more than 70% and gonorrhea by roughly 50% in the supporting trials.17 If doxy-PEP is part of your routine, it travels like any medication: original packaging, doctor's letter if desired, and the same 200 mg-per-24-hours cap no matter the time zone.17

Condom access varies enormously by destination — reliably available in some countries, harder to find or lower-quality in others — so packing what you need rather than counting on local pharmacies is the safer default for any trip. If you're traveling with an HIV-negative partner in a mixed-status couple, PrEP — whether daily oral tablets or the twice-yearly injectable Yeztugo — should be planned with the same lead time as any other medication logistics discussed in this guide: enough runway before departure to confirm supply, refills, and (for the injectable option) whether the trip falls near an injection date.10

Insurance and getting ART if you lose your supply

Most standard travel insurance policies exclude coverage for pre-existing conditions, which technically includes HIV.3 Some insurers do offer specific policies covering pre-existing conditions; it's worth asking directly rather than assuming exclusion. CDC recommends reviewing whether your health insurance covers care outside the U.S. at all, and considering supplemental travel health insurance plus medical evacuation coverage separately — carrying a copy of your insurance card in your travel documents, not just at home.1

If your ART supply is lost, stolen, or destroyed abroad, several backup layers exist before "go without treatment" becomes a real risk. Your home HIV clinic can often call in an emergency prescription to a major international pharmacy chain, and the nearest U.S. embassy or consulate keeps lists of English-speaking, HIV-informed physicians.1 The WHO's Model List of Essential Medicines includes multiple antiretroviral drug classes specifically because they need to be reliably available in health systems worldwide.18 Never buy ART informally or without a pharmacy label; counterfeit HIV medications are a documented problem in some regions, and a fake pill is worse than a missed dose.8

Discrimination and rights — working, studying, and living abroad

The line between "can I visit" and "can I stay" is where most real HIV-related travel discrimination lives. GNP+, the Global Network of People Living with HIV, is a global advocacy network run by and for people living with HIV that tracks and campaigns on travel and residence discrimination as one of its core human-rights portfolios.19

"UHC will only succeed when our voices, our leadership, and our lived experience shape the services and care we rely on to stay alive." — Florence Riako Anam, Co-Executive Director, GNP+ (Global Network of People Living with HIV), December 202519

That principle — that people living with HIV should shape the policies that govern their own mobility — is exactly what's driven every restriction removal in this guide, from Namibia's 2010 reform to New Zealand's 2021 change. It's also why GNP+'s continued position on countries like the UAE matters even where nothing has changed yet: sustained, named advocacy is the documented mechanism by which restrictions have historically fallen.5

For anyone considering a multi-year posting, degree program, or long-term relocation abroad, the practical rights questions are concrete: does the destination require HIV testing for your visa category; does it allow personal import of ART; and does its healthcare system provide HIV care to non-citizens at all. Your own embassy in the destination, and often the destination's embassy at home, are the most reliable sources for a current answer — asking generically about "chronic condition" medical screening gets you that answer without disclosing status.1

Special populations — trans travelers, youth, and aging PLWH

Trans people living with HIV

Trans travelers living with HIV carry two layers of documentation planning at once: HIV-related logistics covered throughout this guide, plus gender marker and identity document consistency across passport, visa, and any secondary ID. Hormone therapy should travel under the same original-packaging, doctor's-letter principle as ART.1 Countries with the strictest HIV entry rules frequently also have the least trans-inclusive legal frameworks, so weigh destination choice with both factors in mind.

Youth living with HIV and parental logistics

For young people traveling with parents or guardians, the documentation load shifts to the accompanying adult: the clinician's letter should list medications by generic and brand name, and custody documentation may be worth carrying if the child travels without both parents. Plan school or camp travel abroad with the same 4-to-6-week clinician runway as any other trip.

Aging PLWH and comorbidity planning

Older people living with HIV are more likely to be managing comorbidities — cardiovascular disease, kidney function changes, bone density — alongside HIV, so travel medicine consultations benefit from covering the full medication list. This is also the population for whom the RSV vaccine recommendation is most relevant: recommended for everyone 75 and older regardless of HIV status, and for adults 60 to 74 with elevated risk factors, a category that explicitly includes moderate or severe immunocompromise.1 See our companion page on HIV and aging.

Faith-based travel — pilgrimage and HIV status

Hajj and Umrah deserve direct, factual treatment rather than vague caution, because the actual policy is more specific than "Saudi Arabia restricts HIV." For the 2026 Hajj season, Saudi authorities introduced a mandatory medical fitness certificate through the official Nusuk platform, screening for conditions that could make the physically demanding pilgrimage unsafe: severe heart failure, advanced kidney failure requiring dialysis, uncontrolled chronic pulmonary disease, active cancer under immunosuppressive treatment, and active infectious diseases including open tuberculosis.20 HIV status itself is not named as an automatic disqualifier in the published 2026 requirements, and the State Department's Saudi Arabia advisory notes no HIV-related restrictions for travelers on temporary visas, which covers most Hajj and Umrah categories.4 The disqualifying criteria center on active, unstable illness — not someone with well-controlled HIV on stable ART.

The practical guidance mirrors every other section of this guide: carry ART in original packaging, bring a doctor's letter, and if any acute or opportunistic infection is active, postponing the trip is the medically sound choice — the same standard applied to any traveler with unstable illness.20 UNAIDS' broader work with faith communities has long emphasized that HIV status should never be a barrier to religious practice or community belonging.1

Emergency scenarios — theft, disaster, hospitalization, medevac

Planning for what goes wrong is not pessimism; it's the same due diligence any traveler does for a lost passport, applied to a specific, manageable scenario. Here is what actually helps in the moment:

Florida — a real departure and return hub for PLWH

Florida's geography makes it one of the country's most active gateways for exactly the kind of international travel this guide covers. Miami International Airport (MIA) is one of the busiest U.S. gateways to Latin America and the Caribbean, and Fort Lauderdale-Hollywood International (FLL) adds a second major South Florida hub — together the natural departure and return point for a large share of Florida's people living with HIV who travel to the Caribbean, Central America, and South America.

Cruise travel

Cruise ships carry their own medical logistics. Most onboard medical centers stock a limited formulary and are not positioned to manage ongoing HIV care — your full trip supply of ART needs to come with you rather than relying on the ship. Ports of call in the Caribbean vary in local HIV-related entry rules, so checking specific islands on a cruise itinerary against the UNAIDS and Positive Destinations databases before booking is worth the ten minutes it takes.6

Snowbird travel

Florida's large seasonal population — retirees and remote workers who split the year between Florida and a Caribbean or Latin American home base — faces a version of the "long-term stay" planning this guide covers, just repeated annually. Treat each seasonal move like the 90-day-plus scenario described earlier: a 90-day prescription supply where possible, a doctor's letter refreshed each season, and a check of current entry and residence rules rather than assuming last year's information still holds.1 See our companion page on finding care.